home > drugs a-z list > rituxan (rituximab) drug center

Recommended Topic Related To:

Rituxan

Non-Hodgkin's lymphoma facts

  • NHL is a cancer that originates in the lymphatic system.
  • About 66,000 patients are diagnosed yearly, and approximately 18,000 patients die of NHL yearly in the U.S.
  • There are several subtypes of NHL, each requiring different treatments.
  • Symptoms include swollen lymph nodes, weight loss, fever, and night sweats.
  • NHL is staged on a 1-4 scale with A (no associated symptoms like fever, weight loss, or night sweats) and B subtypes.
  • Staging the cancer is important to determine treatment and predict the outcome of treatment.
  • Depending on the stage and type of NHL, treatment can include chemotherapy, biological therapy, stem cell transplant, and/or radiation therapy.

What is non-Hodgkin's lymphoma?

Non-Hodgkin's lymphoma is a type of cancer that originates in the lymphatic system. It is estimated to be the sixth most common cancer in the Unite...

Rituxan

font size

Rituxan Drug Center

Medical Editor: John P. Cunha, DO, FACOEP

Rituxan (rituximab) is used in combination with other cancer medicines to treat non-Hodgkin's lymphoma. It is also used in combination with another drug called methotrexate to treat symptoms of adult rheumatoid arthritis. Rituxan is a cancer medication. Common side effects include headache, fever, chills, nausea, heartburn, flushing, weakness, or dizziness.

Rituxan is administered under a physician's supervision. The dose of Rituxan varies depending on the disorder being treated and the number of infusions (doses) needed. Rituxan may interact with cisplatin, adalimumab, auranofin, azathioprine, cyclosporine, etanercept, infliximab, leflunomide, minocycline, sulfasalazine, blood pressure medications, or medication to treat malaria. Tell your doctor all medications you use. During pregnancy, Rituxan must not be used unless prescribed due to a risk of harm to the fetus. Becoming pregnant is not recommended during treatment with this medication and for at least 12 months after treatment is finished. Consult your doctor about using birth control. It is unknown if this drug passes into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug is not recommended. Do not begin breast-feeding until treatment is finished and blood tests show no more rituximab in your body.

Our Rituxan (rituximab) Drug Center provides a comprehensive view of available drug information as well as related drugs, user reviews, supplements, and diseases and conditions articles.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Rituxan Prescribing Information: Indications & Dosage

Non-Hodgkin's Lymphoma (NHL)

Rituxan® (rituximab) is indicated for the treatment of patients with:

  • Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent
  • Previously untreated follicular, CD20-positive, B-cell NHL in combination with first line chemotherapy and, in patients achieving a complete or partial response to Rituxan in combination with chemotherapy, as single-agent maintenance therapy.
  • Non-progressing (including stable disease), low-grade, CD20-positive, B-cell NHL as ...

Read the complete drug monograph for Rituxan »

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Rituxan Patient Information: Side Effects

Some people receiving a rituximab injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you feel dizzy, weak, nauseated, light-headed, itchy, or if you have a fever, chills, muscle pain, sneezing, sore throat, trouble breathing, or pain in your chest or shoulders. Infusion reactions often occur within the first 24 hours after the start of your rituximab infusion.

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, o...

Read the complete patient information for Rituxan »

What is Consumer information?

A concise overview of the drug for the patient or caregiver from First DataBank.

Rituxan Consumer Information: Uses

Rituximab is used alone or with other medications to treat certain types of cancer (e.g., non-Hodgkin's lymphoma). It is a type of medication called a monoclonal antibody. It works by attaching to certain blood cells from your immune system (B cells) and killing them. It is also used with other monoclonal antibodies and radioactive drugs to treat certain cancers.

Rituximab is also used with methotrexate to treat moderate-to-severe forms of rheumatoid arthritis. It is usually used for arthritis only after other medications have not worked. It can decrease joint pain and swelling. It is also ...

Read the complete consumer information for Rituxan »

What is Rituxan Consumer Information?

Warnings - Uses - How to Use - Side Effects - Precautions - Drug Interactions and More

Rituxan - User Reviews

Rituxan User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Rituxan sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.